| Laura J Richard, | |
|
195 Collyer St Ste 301, Providence, RI 02904-1869 | |
| (401) 793-4080 | |
| (401) 793-4110 |
| Full Name | Laura J Richard |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 195 Collyer St Ste 301, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871659615 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 61 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura J Richard, 195 Collyer St Ste 301, Providence, RI 02904-1869 Ph: () - | Laura J Richard, 195 Collyer St Ste 301, Providence, RI 02904-1869 Ph: (401) 793-4080 |
News Archive
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
The 99 Cents Only Stores is partnering with the American Red Cross L.A. Region's PrepareLA campaign by promoting to the broader LA community the many affordable disaster items needed for emergency preparedness kits carried regularly in 99 Cents Only Stores.
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced today that it has reached an agreement with the U.S. Food and Drug Administration under a special protocol assessment for a global pivotal Phase 3 trial with aldoxorubicin as a treatment for patients with soft tissue sarcomas who have relapsed or were refractory following prior treatment with chemotherapy.
› Verified 4 days ago
Caitlin Kelly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Allison Marie Hourahan, OTR/L, CLT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 668 Eddy St, Providence, RI 02903 Phone: 401-274-1122 | |
Ms. Diana Navarro, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 353 Blackstone Blvd, Providence, RI 02906 Phone: 401-273-6565 | |
Mrs. Kelly L. Klampert, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Kristen Laurie Bourque, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9165 Fax: 401-533-9105 | |
Miss Christa N Fadden, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-8661 | |
Miss Melissa Anne Barlow, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 401-793-5080 |